Bruno Beccarini Crescenzi
Biographic Data
| ID | 7961541 |
|---|---|
| NAME | Bruno Beccarini Crescenzi |
| GIVEN NAMES | Bruno Beccarini |
| FAMILY NAME | Crescenzi |
| SIGNATURE | CRESCENZI B B |
| AFFILIATIONS | University of Siena |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2019 |
| LATEST PUBLICATION YEAR | 2019 |
| H-INDEX | 0 |
Feasibility, Adherence and Efficacy of Liraglutide Treatment in a Sample of Individuals With Mood Disorders and Obesity
Background: Liraglutide is a once-daily injectable medication approved for the treatment of obesity. Hereby we report the feasibility, adherence and efficacy of liraglutide treatment in a sample of individuals with mood disorders and obesity. Methods and Sample: Twenty-nine patients with Bipolar or Major Depressive Disorder received liraglutide once daily subcutaneously at a dose gradually titrated from 0.6 to 3 mg. All patients were obese and ha…
Prevalence and Correlates of Vitamin D Deficiency in a Sample of 290 Inpatients With Mental Illness
Introduction: Vitamin D inadequacy or deficiency (VDID) has been reported in a high percentage of otherwise healthy individuals. Factors that may contribute to the high prevalence of VDID in people with mental disorders include diet low in vitamin D, poor sunlight exposure, decrease in cutaneous vitamin D synthesis, intake of certain medications, poor mobility, excessive alcohol intake, and tobacco smoking. VDID has been correlated to a host of a…
No prominent works on this page.
Feasibility, Adherence and Efficacy of Liraglutide Treatment in a Sample of Individuals With Mood Disorders and Obesity
Background: Liraglutide is a once-daily injectable medication approved for the treatment of obesity. Hereby we report the feasibility, adherence and efficacy of liraglutide treatment in a sample of individuals with mood disorders and obesity. Methods and Sample: Twenty-nine patients with Bipolar or Major Depressive Disorder received liraglutide once daily subcutaneously at a dose gradually titrated from 0.6 to 3 mg. All patients were obese and ha…
Prevalence and Correlates of Vitamin D Deficiency in a Sample of 290 Inpatients With Mental Illness
Introduction: Vitamin D inadequacy or deficiency (VDID) has been reported in a high percentage of otherwise healthy individuals. Factors that may contribute to the high prevalence of VDID in people with mental disorders include diet low in vitamin D, poor sunlight exposure, decrease in cutaneous vitamin D synthesis, intake of certain medications, poor mobility, excessive alcohol intake, and tobacco smoking. VDID has been correlated to a host of a…
Internal Medicine (2 works) · Medicine (2 works) · Psychiatry (2 works) · Bipolar Disorder and Treatment (1 works) · Depression (economics (1 works) · Diabetes mellitus (1 works) · Diabetes Treatment and Management (1 works) · Endocrinology (1 works) · Fibromyalgia and Chronic Fatigue Syndrome Research (1 works) · Liraglutide (1 works)